Preface
xi
P/N 85213-30, Manual revision: B
I
NTRODUCING
THE
MCS+
TOTAL
APHERESIS
DEVICE
What is the
purpose of this
manual?
This manual is intended to supply anyone involved in using Haemonetics apher-
esis equipment with the essential tool for safe and successful operation – infor-
mation. Using this tool of information, the operator can acquire knowledge to be
applied throughout all levels of operating experience. This body of information
should be consulted whenever necessary, starting from the initial contact with
Haemonetics technology, in order to attain:
!
An awareness of the purpose of the device and the implications of its col-
lection procedures for the donor/patient and the apheresis center.
!
An understanding of how to safely operate the Haemonetics system, cor-
rectly install the appropriate disposable material, and troubleshoot any dif-
ficulties.
!
An ability to consistently apply the principles behind safe operation, prop-
er maintenance and correct handling to ensure optimal, quality apheresis
results.
This manual covers MCS+ device information for list numbers LN9000-220-E,
LN9000-220-ED, LN9000-220-EW, and LN9000-110-EWC. Information that is
specific to a certain protocol (disposable set installation and how to run the
protocol), is located in the protocol manuals.
What is apheresis
technology?
Apheresis is the general term used to describe the selective removal and collec-
tion of one or more individual components which together form whole blood.
This term can be subdivided into two categories:
!
Cytapheresis: selective removal of one or more of the formed, cellular
components of whole blood. These elements include erythrocytes, throm-
bocytes, leukocytes and stem cells.
!
Plasmapheresis: selective removal of plasma, the liquid suspension medi-
um of blood. Plasma contains elements referred to as fractional compo-
nents, such as clotting proteins and immunoglobulins.
Apheresis Technology permits:
!
The collection and separation of whole blood.
!
The selective removal of specific components.
!
The subsequent return of the remaining components
to the donor/patient.
Содержание MCS+
Страница 2: ...2002 2006 Haemonetics Corporation All rights reserved...
Страница 10: ...x Preface P N 85213 30 Manual revision B The Haemonetics MCS LN09000 220E ED...
Страница 20: ......
Страница 30: ......
Страница 81: ...Maintaining the MCS Equipment 5 7 P N 85213 30 Manual revision B...
Страница 85: ......
Страница 86: ...5 12 Maintaining the MCS Equipment P N 85213 30 Manual revision B...
Страница 100: ......